Vancomycin plus nafcillin salvage for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia following daptomycin failure: a case report and literature review

Vancomycin plus nafcillin salvage for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia following daptomycin failure: a case report and literature review

Background: Evidence supporting beta-lactam plus vancomycin synergy for methicillin-resistant Staphylococcus aureus (MRSA) continues to grow. Current in vivo evidence demonstrates that combination therapy is associated with shorter time to blood sterilization than vancomycin monotherapy. However, th...

Full description

Bibliographic Details
Main Authors:	Paul O. Lewis, Regan E. Sevinsky, Paras D. Patel, Matthew R. Krolikowski, David B. Cluck
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-01-01
Series:	Therapeutic Advances in Infectious Disease
Online Access:	https://doi.org/10.1177/2049936118797404

Similar Items

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible <it>Staphylococcus aureus </it>bacteremia
by: McGregor Jessina C, et al.
Published: (2011-10-01)

Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
by: Marguerite L. Monogue, et al.
Published: (2018-09-01)

Successful Clearance of Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia with Daptomycin, Linezolid, and Meropenem Salvage Therapy
by: Grant Shaddix, et al.
Published: (2019-01-01)

Septic thrombophlebitis with persistent methicillin-resistant Staphylococcus aureus bacteremia and de novo resistance to vancomycin and daptomycin
by: Yael Koton, et al.
Published: (2017-05-01)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
by: Chih-Jung Chen, et al.
Published: (2020-07-01)

Daptomycin-Nonsusceptible, Vancomycin-Intermediate, Methicillin-Resistant Staphylococcus aureus Endocarditis
by: Ryan Yu, et al.
Published: (2012-01-01)

Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
by: Dong Hyun Oh, et al.
Published: (2018-01-01)

Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline
by: Omar Ahmad, et al.
Published: (2019-11-01)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
by: Jose Maria Aguado, et al.
Published: (2011-06-01)

Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
by: Steven N Leonard
Published: (2012-01-01)

The Evaluation of Vancomycin and Daptomycin Susceptibility by E-Test Method in Methicillin-Resistant Staphylococcus aureus Isolates
by: Firdevs AKSOY, et al.
Published: (2012-03-01)

Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus
by: Michael J. Salazar, et al.
Published: (2020-03-01)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
by: Rafael San-Juan, et al.
Published: (2016-06-01)

Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
by: Mitchell J. Schwaber, et al.
Published: (2003-06-01)

Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant bacteremia after monotherapy failure
by: Joseph Patrik Hornak, et al.
Published: (2019-11-01)

Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
by: Hao-Yuan Lee, et al.
Published: (2015-01-01)

A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections
by: Matthew A. Miller, et al.
Published: (2020-04-01)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant <it>Staphylococcus aureus </it>bacteremia
by: Honda Hitoshi, et al.
Published: (2011-12-01)

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.
by: Atsushi Komoto, et al.
Published: (2018-01-01)

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
by: Mori T, et al.
Published: (2012-02-01)

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study
by: David B. Huang, et al.
Published: (2017-01-01)

Ceftaroline in the treatment of methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus bacteremia and infective endocarditis in end-stage renal disease
by: Kristen Fuhrmann, et al.
Published: (2013-09-01)

A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study
by: Shirin Kalimuddin, et al.
Published: (2018-06-01)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
by: Navaneeth Narayanan, et al.
Published: (2019-02-01)

The Use of Daptomycin and Quinolones Combination in Staphylococcus aureus Bacteremia: An In Vitro Synergistic Study
by: Derya KETEN, et al.
Published: (2013-09-01)

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid
by: Johanna Marcela Vanegas Múnera, et al.
Published: (2017-09-01)

Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study
by: Altun, G., et al.
Published: (2022)

Methicillin- and vancomycin-resistant Staphylococcus aureus colonization
by: Marcelo Jenné Mimica
Published: (2012-04-01)

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it>Staphylococcus aureus </it>in a renal transplant recipient with Fabry-Anderson disease
by: Polilli Ennio, et al.
Published: (2012-03-01)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01)

Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital
by: Andreia Paredes Damasco, et al.
Published: (2019-03-01)

Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
by: Robby Markwart, et al.
Published: (2021-05-01)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
by: Daniel J. Lachant, et al.
Published: (2013-01-01)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
by: Diana Panesso, et al.
Published: (2015-10-01)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
by: Jiun-Ling Wang, et al.
Published: (2004-09-01)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
by: Viviana Cafiso, et al.
Published: (2020-08-01)

Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
by: Reenar Yoo, et al.
Published: (2021-01-01)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
by: Sheetal Chitnis, et al.
Published: (2013-01-01)

Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
by: Bradley M. Wright, et al.
Published: (2011-01-01)

Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
by: Sara Alosaimy, et al.
Published: (2020-04-01)